Biotech Research News: H.C. Wainwright & Co. Initiates Coverage of GenSpera (OTCQB:GNSZ) with a Buy Rating
New York, NY - December 17, 2014 (Investorideas.com Biotech Newswire) Market Exclusive announces that H.C. Wainwright & Co has initiated coverage with a Buy rating of GenSpera, Inc. (OTCQB:GNSZ) and a 12-month target price of $2.